5-(2-Fluorophenyl)oxazole-4-carboxylic acid, 95.0%, 1g

3-Benzyloxypropyl(triphenyl)phosphonium bromide, 98+%, 1g

4-Bromo-5-chloronaphthalen-2-ol, 97%, 250mg

3'-Methyl-biphenyl-3-ylamine hydrochloride, 95.0%, 1g

2-(4-Chloro-benzylamino)-ethanol, 250mg

EGTA, 100 g

2-Methoxy-4-nitrobenzenesulfonyl chloride, 97.0%, 5g

8-ethyl-4-(4-methylbenzoyl)-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxylic acid, 95.0%, 1g

Methyl 2-amino-3-fluorobenzoate, 95.0%, 5g

5-Bromo-3-methyl-1H-indazole, 95.0%, 5g

1-Hexanol, min. 98%, for synthesis, 2.5 L, glass packaging

(S)-6-AMINO-1,4-OXAZEPAN-5-ONE, 95.0%, 250mg

(3aR,7aS)-2-Benzylhexahydropyrano[3,4-c]pyrrol-4(1H)-one, 95%, 100mg